RxDoctor Payments Data
★ My doctorsLook up a doctor →

Sholomo Lanes, MD

Vascular Surgery · Hollywood, FLNPI 1649584251

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 134 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,104 and has fallen 74.3% since, to $283 in 2025. That places this record below the midpoint for vascular surgery clinicians in FL, where the typical reported total is $6,364.

$3,302in general payments, 2019–2025

Across 134 payments — averaging $24.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$773
  • Sun Pharmaceutical Industries Inc.$297
  • Johnson & Johnson$263
  • Novartis$223
  • Revance Therapeutics, Inc.$220
  • Regeneron Healthcare Solutions, Inc.$204
  • plus $1K from 20 others
$262,477in research payments, 2019–2025

Across 33 payments — averaging $7953.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • UCB SA$262K

What the payments were for

  • Food & beverage$3,302100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie36$773
Sun Pharmaceutical Industries Inc.15$297
Johnson & Johnson12$263
Novartis9$223
Revance Therapeutics, Inc.2$220
Regeneron Healthcare Solutions, Inc.7$204
Ortho Dermatologics, A Division Of Bausch Health US, LLC11$188
Incyte Corporation8$185
Lilly USA, LLC7$185
Bard Peripheral Vascular, Inc.1$169
Prugen, Inc. Pharmaceuticals1$75
BD3$71
Almirall LLC3$64
UCB, Inc.3$60
VYNE Pharmaceuticals Inc.2$54
Amgen2$44
Arcutis Biotherapeutics, Inc.2$44
Biofrontera Inc.2$39
LNHC, Inc1$22
Boehringer Ingelheim1$22
Bristol Myers Squibb1$21
Solta Medical, A Division Of Bausch Health US, LLC1$18
Merz North America, Inc.1$18
Galderma Laboratories, L.p.1$15
Pierre Fabre Pharmaceuticals, Inc.1$14
DUSA Pharmaceuticals, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,302 in reported general payments places this provider in the 35th percentile of 385 vascular surgery providers in Florida.

See all vascular surgery providers in Florida →

Medicare billing

Part B allowed, 2024
$26,540
Medicare patients
55
Services billed
141

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in Hollywood

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →